HF
MRKR icon

HRT Financial’s Marker Therapeutics MRKR Stock Holding History

HRT Financial’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-11,852
Closed -$15K – 4929
2026
Q1 		$15K Sell
11,852
-2,085
-15% -$3.31K ﹤0.01% 3597
2025
Q4 		$20K Buy
+13,937
New +$15.8K ﹤0.01% 2982
2023
Q3 		– Sell
-12,469
Closed -$38K – 2832
2023
Q2 		$38K Buy
+12,469
New +$21.7K ﹤0.01% 2042
2021
Q4 		– Sell
-4,922
Closed -$83K – 3740
2021
Q3 		$83K Buy
4,922
+365
+8% +$7.48K ﹤0.01% 2947
2021
Q2 		$127K Buy
+4,557
New +$120K ﹤0.01% 2535

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

HRT Financial's MRKR Position: Q2 2026 in Review

HRT Financial sold out of Marker Therapeutics (MRKR) in Q2 2026, closing a stake of 11,852 shares — an estimated $15K sold.

HRT Financial first reported a position in MRKR in Q2 2021 and held it in 5 quarters. The position peaked at $127K in Q2 2021. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

  • HRT Financial reported no remaining Marker Therapeutics position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 11,852 Marker Therapeutics shares in Q2 2026, an estimated $15K.
  • HRT Financial first reported a position in Marker Therapeutics in Q2 2021 and held it in 5 quarters.
  • HRT Financial's Marker Therapeutics position peaked at $127K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.